A retrospective study of treatment persistence and adherence to α-blocker plus antimuscarinic combination therapies, in men with LUTS/BPH in the Netherlands
Background: To assess treatment persistence and adherence in men ≥45 years of age with lower urinary tract symptoms (LUTS) associated with benign prostatic hyperplasia (BPH), using prescription records from the Netherlands IMS Lifelink™ LRx database. Methods: In this retrospective, observational cohort study, we identified men who received combination therapy with an α-blocker plus an antimuscarinic (e.g. solifenacin or tolterodine) between 1 November 2013 and 31 October 2014. Treatment could be received as a fixed-dose combination (FDC) tablet or as two drugs administered together (concomitan... Mehr ...
| Verfasser: | |
|---|---|
| Dokumenttyp: | Artikel |
| Erscheinungsdatum: | 2017 |
| Reihe/Periodikum: | Drake , M J , Bowditch , S , Arbe , E , Hakimi , Z , Guelfucci , F , Amri , I & Nazir , J 2017 , ' A retrospective study of treatment persistence and adherence to α-blocker plus antimuscarinic combination therapies, in men with LUTS/BPH in the Netherlands ' , BMC Urology , vol. 17 , 36 . https://doi.org/10.1186/s12894-017-0226-2 |
| Schlagwörter: | /dk/atira/pure/core/keywords/centre_for_surgical_research / Centre for Surgical Research / Antimuscarinic / Fixed-dose combination / LUTS/BPH / Treatment persistence / α-blocker |
| Sprache: | Englisch |
| Permalink: | https://search.fid-benelux.de/Record/base-26820656 |
| Datenquelle: | BASE; Originalkatalog |
| Powered By: | BASE |
| Link(s) : | https://hdl.handle.net/1983/8d4a9a18-a80d-4ea0-852d-4a8a59e56cd4 |
